[1]吕建阳,李振国,陈 林,等.吡柔比星联合羟基喜树碱膀胱灌注对老年浅表性膀胱肿瘤经尿道膀胱肿瘤电切术后患者复发风险、生存时间及血清学指标的影响[J].陕西医学杂志,2021,50(3):345-348,352.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.023]
　LYU Jianyang,LI Zhenguo,CHEN Lin,et al.Effect of intravesical instillation with pirarubicin and hydroxycamptothecin on the risk of recurrence,survival time and serological indexes in elderly patients with superficial bladder canner after TURBT[J].,2021,50(3):345-348,352.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.023]
点击复制

吡柔比星联合羟基喜树碱膀胱灌注对老年浅表性膀胱肿瘤经尿道膀胱肿瘤电切术后患者复发风险、生存时间及血清学指标的影响
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
50
期数:
2021年3期
页码:
345-348,352
栏目:
药物与临床
出版日期:
2021-03-01

文章信息/Info

Title:
Effect of intravesical instillation with pirarubicin and hydroxycamptothecin on the risk of recurrence,survival time and serological indexes in elderly patients with superficial bladder canner after TURBT
作者:
吕建阳1; 李振国1; 陈 林1; 张 文2; 刘殿刚3
(1.北京市第六医院泌尿外科,北京 100007; 2.北京丰台医院泌尿外科,北京 100071; 3.首都医科大学宣武医院普通外科,北京 100053)
Author(s):
LYU Jianyang; LI Zhenguo; CHEN Lin; ZHANG Wen; LIU Diangang
(Department of Urology,Beijing Sixth Hospital,Beijing 100007,China)
关键词:
浅表性膀胱肿瘤;  经尿道膀胱肿瘤电切术;  吡柔比星;  羟基喜树碱;  膀胱灌注;  老年人
Keywords:
Superficial bladder canner;  TURBT;  Pirarubicin;  Hydroxycamptothecin;  Bladder perfusion;  Aged
分类号:
R 737.14
DOI:
DOI:10.3969/j.issn.1000-7377.2021.03.023
文献标志码:
A
摘要:
目的:探讨吡柔比星联合羟基喜树碱膀胱灌注化疗对老年浅表性膀胱肿瘤(SBC)经尿道膀胱肿瘤电切(TURBT)术后患者复发风险、生存时间及血清学指标的影响。方法:将进行TURBT术的SBC患者126例随机分为两组。吡柔比星组采用吡柔比星膀胱灌注化疗。联合组采用吡柔比星联合羟基喜树碱膀胱灌注化疗。对比两组患者术后复发率、生存时间、近期疗效、血清学指标[可溶性细胞间黏附分子-1(sICAM-1)、E-钙粘素(E-cadherin)、肝细胞黏附分子(hepaCAM)、成纤维细胞生长因子(FGF)、基质金属蛋白酶(MMP)以及血管内皮生长因子(VEGF)]及不良反应发生情况。结果:术后48个月,联合组患者累计复发率低于吡柔比星组(P<0.05)。联合组患者1年生存率、2年生存率、无进展生存时间、总生存时间均高于吡柔比星组(均P<0.05)。联合组sICAM-1、FGF、MMP-2、MMP-9、VEGF水平均低于吡柔比星组,E-cadherin、hepaCAM水平均高于吡柔比星组(均P<0.05)。联合组总有效率、临床收益率均高于吡柔比星组(均P<0.05)。联合组不良反应总发生率低于吡柔比星组(P<0.05)。结论:吡柔比星联合羟基喜树碱膀胱灌注可降低患者复发率和不良反应发生率,提高近期疗效和生存时间。
Abstract:
Objective:To investigate the effect of intravesical instillation with pirarubicin and hydroxycamptothecin on the risk of recurrence,survival time and serological indexes in elderly patients with superficial bladder canner(SBC)after transurethral resection of bladder tumor(TURBT).Methods:126 SBC patients undergoing TURBT were randomly divided into two groups.The pirarubicin group was treated with intravesical instillation of pirarubicin.The combination group was treated with intravesical instillation of pirarubicin and hydroxycamptothecin.The postoperative recurrence rate,survival time,short-term curative effect,and serological indicators(sICAM-1,E-cadherin,hepaCAM,FGF,MMP and VEGF)and adverse reactions was compared between the two groups.Results:48 months after operation,the cumulative recurrence rate of the combination group was lower than that of pirarubicin group(P<0.05).The 1-year survival rate,2-year survival rate,progression-free survival time,and overall survival time of the combination group were higher than those of the pirarubicin group(all P<0.05).The levels of sICAM-1,FGF,MMP-2,MMP-9,and VEGF in the combination group were lower than those in the pirarubicin group,and the levels of E-cadherin and hepaCAM were higher than those in the pirarubicin group(all P<0.05).The total effective rate and clinical profit rate of the combination group were higher than those of the pirarubicin group(all P<0.05).The total incidence of adverse reactions in the combination group was lower than that in the pirarubicin group(P<0.05).Conclusion:Intravesical instillation of pirarubicin combined with hydroxycamptothecin can reduce the rate of recurrence and adverse reactions,and improve the short-term efficacy and survival time.

参考文献/References:

[1] Sandy H,Fang EC,Wick SL,et al.Reduction of costs for pelvic exenteration performed by high volume surgeons:Analysis of the maryland health service cost review commission database[J].American Surgeon,2016,82(1):46-52.
[2] 黄文杰,袁朝勇,刘 蕾.多柔比星辅助治疗对浅表性膀胱癌患者TURBT术后血清炎症因子及肿瘤标志物的影响[J].现代预防医学,2019,46(4):747-751.
[3] 刘 杰,崔 伟,车 梓,等.经尿道膀胱肿瘤电切术治疗肌层浸润性膀胱癌的临床疗效[J].山东大学学报:医学版,2018,56(7):81-85.
[4] Jun YP,Jun HH,Doo K,et al.Magnesium and bladder discomfort after transurethral resection of bladder tumor[J].Anesthesiology,2020,133(1):64-77.
[5] Messing EM.A more thorough transurethral resection[J].Bladder Cancer,2017,3(1):75-77.
[6] 李 靖,王 斌,张 震,等.膀胱灌注流量及膀胱充盈程度在膀胱热灌注化疗中的应用[J].实用医学杂志,2020,36(15):2167-2169.
[7] 吴 城,胡 立,江 能,等.闭孔神经阻滞复合全身麻醉在经尿道膀胱肿瘤电切术老年患者中的应用[J].中华老年医学杂志,2020,39(5):569-572.
[8] 张建伟.经尿道钬激光膀胱肿瘤剜除术治疗浅表性膀胱肿瘤72例临床分析[J].江苏医药,2019,45(6):627-628.
[9] 贾 宾,蔡 兵,王天龙,等.清醒镇静镇痛在老年患者浅表性膀胱肿瘤激光气化切除术中的可行性[J].实用医学杂志,2016,32(14):2256-2258,2259.
[10] 邱 敏,田晓军,徐楚潇,等.NBI辅助TURBT治疗膀胱多发肿瘤的效果及手术经验[J].现代泌尿外科杂志,2019,24(12):1000-1003.
[11] 李文亮,李春明,杨国山.膀胱癌组织中TopoⅡα表达水平及与TURBT术后复发的关系[J].现代肿瘤医学,2020,28(21):3756-3759.
[12] 马莉莉,林其敏,韩 晟,等.吡柔比星与表柔比星在表浅性膀胱癌术后灌注预防复发中的循证药物经济学研究[J].中国药学,2016,25(2):145-149.
[13] Zhang Y,Ma XY,Zhang T,et al.Protective effects of apocynum venetum against pirarubicin-induced cardiotoxicity[J].American Journal of Chinese Medicine,2019,47(5):1075-1097.
[14] Chen B,Zhong XM,Yang ZW.Nanocochleates as the potential delivery systems for oral antitumor of hydroxycamptothecin[J].Journal of Biomedical Nanotechnology,2018,14(7):1339-1346.
[15] Xiao LL,Hui C,Yu S,et al.Hydroxycamptothecin prevents intraarticular scar adhesion by activating the PERK signal pathway[J].Eur J Pharmacol,2017,810:36-43.
[16] 程国华,鲍辛南.注射用羟基喜树碱与羟基喜树碱注射液稳定性的研究[J].中国医院药学杂志,2003,23(12):741-742.
[17] 徐 安,方 震,杨登科,等.羟基喜树碱联合吡柔比星膀胱灌注预防浅表性膀胱癌复发的效果分析[J].肿瘤药学,2018,8(5):783-786.
[18] 王 蓉,刘付盈,郭海华,等.吡柔比星与羟基喜树碱对浅表性膀胱癌的预防及安全性的meta分析[J].中国现代应用药学,2017,34(7):1035-1041.
[19] 李伟亮,谢 宁,吴振启.经尿道膀胱肿瘤电切术后使用吡柔比星或丝裂霉素定期灌注化疗治疗膀胱肿瘤临床研究[J].陕西医学杂志,2016,45(7):902-904.
[20] 李明兴,宋士强,宋春景,等.三联膀胱灌注化疗方案对行TURBT术浅表型膀胱癌的疗效[J].中国临床研究,2018,31(8):1037-1042.

相似文献/References:

[1]强永春,李 佳.经尿道膀胱肿瘤电切术后吉西他滨膀胱热灌注化疗老年浅表性膀胱癌疗效与安全性研究[J].陕西医学杂志,2021,50(2):184.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.015]
　QIANG Yongchun,LI Jia.Efficacy and safety of hyperthermic bladder chemotherapy with gemcitabine after transurethral resection of bladder tumors in elderly with superficial bladder cancer[J].,2021,50(3):184.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.015]
[2]焦向宁,董维平,路 璐,等.浅表性膀胱癌经尿道膀胱癌等离子电切术治疗后患者氧化应激反应水平与疼痛相关性研究[J].陕西医学杂志,2023,52(1):32.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.007]
　JIAO Xiangning,DONG Weiping,LU Lu,et al.Correlation between oxidative stress and pain after transurethral resection of bladder cancer in patients with superficial bladder cancer[J].,2023,52(3):32.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.007]

备注/Memo

备注/Memo:
基金项目:北京市卫生系统高层次卫生技术人才培养计划项目(2015-3-066)
更新日期/Last Update: 2021-03-04